Nan Fung Trinity’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1M Hold
142,083
– – 1.35% 29
2026
Q2
$18.9M Buy
142,083
+13,143
+10% +$1.49M 1.87% 20
2026
Q1
$14.4M Buy
128,940
+15,575
+14% +$1.84M 1.58% 27
2025
Q4
$15.3M Buy
113,365
+12,000
+12% +$1.31M 1.21% 38
2025
Q3
$8.61M Buy
+101,365
New +$6.21M 0.86% 42

Other funds holding ABVX

Nan Fung Trinity's ABVX Position: Q3 2026 in Review

Nan Fung Trinity held its Abivax (ABVX) position steady in Q3 2026 at 142,083 shares worth $14.1M. The position accounts for 1.35% of the portfolio, ranked #29.

Nan Fung Trinity first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $18.9M in Q2 2026. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Nan Fung Trinity held 142,083 shares of Abivax worth $14.1M as of Q3 2026.
  • Nan Fung Trinity left its Abivax share count unchanged in Q3 2026.
  • Abivax made up 1.35% of Nan Fung Trinity's portfolio in Q3 2026, its #29 holding.
  • Nan Fung Trinity first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
  • Nan Fung Trinity's Abivax position peaked at $18.9M in Q2 2026.
  • 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Nan Fung Trinity's 13F filing for Q3 2026, filed 6 Nov 2026.